A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy

DOI10.1007/s11538-012-9722-4zbMath1251.92023OpenAlexW2163228402WikidataQ37293334 ScholiaQ37293334MaRDI QIDQ1758078

Publication date: 7 November 2012

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3822329

zbMATH Keywords

cancer immunotherapy

Mathematics Subject Classification ID

Probabilistic models, generic numerical methods in probability and statistics (65C20) Medical applications (general) (92C50)

Related Items

Mathematical modeling of tumor and cancer stem cells treated with CAR-T therapy and inhibition of TGF-\(\beta\) ⋮ Is the Allee effect relevant in cancer evolution and therapy? ⋮ A cancer treatment based on synergy between anti-angiogenic and immune cell therapies ⋮ A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy ⋮ A mathematical model for pancreatic cancer growth and treatments ⋮ Combination therapies and intra-tumoral competition: insights from mathematical modeling ⋮ Existence of periodic solution for a tumor growth model with vaccine interaction ⋮ An optimal control problem of immuno-chemotherapy in presence of gene therapy ⋮ Ultimate dynamics of the Kirschner-Panetta model: tumor eradication and related problems ⋮ A mathematical model of treatment of cancer stem cells with immunotherapy ⋮ A tumor-Immune interaction model with the effect of impulse therapy ⋮ Modeling the role of immune cell conversion in the tumor-immune microenvironment ⋮ Understanding the interplay of CAR-NK cells and triple-negative breast cancer: insights from computational modeling ⋮ Mathematical analysis on a diffusion model describing the compatibility between two types of tumor cells ⋮ Mathematical modelling of the inhibitory role of regulatory T cells in tumor immune response ⋮ A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies ⋮ A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS ⋮ Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control ⋮ A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications ⋮ A minimal model of T cell avidity may identify subtherapeutic vaccine schedules ⋮ Optimal control of variable-order fractional model for delay cancer treatments ⋮ Dependence of CD8 T cell response upon antigen load during primary infection. ⋮ Optimization of combination therapy for chronic myeloid leukemia with dosing constraints ⋮ Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions ⋮ Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells ⋮ Modeling the stem cell hypothesis: investigating the effects of cancer stem cells and TGF \(- \beta\) on tumor growth ⋮ Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics ⋮ MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS ⋮ Therapy strategy in tumour cells and immune system interaction mathematical model ⋮ Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling ⋮ Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions ⋮ Efficiency of cancer treatments: in silico experiments ⋮ Dynamics of breast cancer under different rates of chemoradiotherapy ⋮ Analysis of stochastic dynamics of tumor with drug interventions ⋮ Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative

Cites Work